Bibliography
- Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108
- Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-71
- Llovet JM, Real MI, Montaña X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-9
- Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-61
- Chia WK, Ong S, Toh HC, et al. Phase II trial of gemcitabine in combination with cisplatin in inoperable or advanced hepatocellular carcinoma. Ann Acad Med Singapore 2008;37:554-8
- Buijs M, Vossen JA, Frangakis C, et al. Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization - single-center experience. Radiology 2008;249:346-54
- Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-90
- Miller S, Stagl J, Wallerstedt DB, et al. Botanicals used in complementary and alternative medicine treatment of cancer: clinical science and future perspectives. Expert Opin Investig Drugs 2008;17:1353-64
- Cho WC, Yip TT, Chung WS, et al. Altered expression of serum protein in ginsenoside Re treated diabetic rats detected by SELDI-TOF MS. J Ethnopharmacol 2006;108:272-9
- Cho WC, Chung WS, Lee SK, et al. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol 2006;550:173-9
- Cui J, Nan KJ, Tian T, et al. Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture. World J Gastroenterol 2007;13:5432-9
- Yin LR, Chen ZX, Zhang SJ, et al. Expression of chromosome ten in liver of athymic mice with hepatocellular carcinoma and the effect of Fuzheng Jiedu Decoction. World J Gastroenterol 2008;14:108-13
- Cheng HM, Tsai MC. Regression of hepatocellular carcinoma spontaneous or herbal medicine related? Am J Chin Med 2004;32:579-85
- Zhang N, Yin Y, Xu SJ, et al. 5-Fluorouracil: mechanisms of resistance and reversal strategies. Molecules 2008;13:1551-69
- Cho WC, Leung KN. In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. J Ethnopharmacol 2007;113:132-41
- Cho WC, Leung KN. In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett 2007;252:43-54
- Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354:1896-900
- Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12
- Cochrane handbook for systematic reviews of interventions 4.2.5. In: Higgins JPT, Green S, editors. The Cochrane Library, Issue 3. Chichester, UK: John Wiley and Sons Ltd, 2005
- Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88
- Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101
- Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34
- Yi C, Ye JF, Wu WG. Clinical study on the alleviation of chronic damage to liver function caused by transcatheter arterial chemoembolization by Chinese medicine. Pharmacol Clin Chin Mater Med 1998;14:39-40
- Xu K, Li ZX, Zhu DY. The effect of Gan Fu Le in interventional treatment of hepatocarcinoma. J Tradit Chin Med 2000;20:185-6
- Hu HL, Chen HC, Xu SW. A study on the treatment of unresectable liver cancers with the combination of transhepatic arterial chemoembolization and Chinese herbs. Henan J Oncol 2001;14:412-13
- Shao ZX, Cheng ZG, Yin XE, et al. Clinical study on treatment of middle-advanced stage liver cancer by combined treatment of hepatic artery chemoembolization with Gan'ai No. I and No. II. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001;21:168-70
- Wang CJ, Liao ZJ, Chen QQ, et al. Herbal medication 960 mixture combined with transcatheter arterial chemoembolization for advanced liver cancer. Chin J Integr Tradit West Med Digestion 2002;10:211-14
- Wu XD, Wang YD, Liu SM, et al. Observation on the enhancing efficacy of transcatheter arterial chemoembolization with traditional Chinese medicine decoction treating stage II or III primary liver cancer. Chin J Integr Tradit West Med Liver Dis 2002;12:43-4
- Xue YB, Zhou XY, Shan SL. Observation on the efficacy of transcatheter arterial chemoembolization combined with traditional Chinese medicine treating middle-advanced liver cancer. Mod J Integr Tradit Chin West Med 2002;11:2218-19
- Yu Y. Observation on clinical efficacy of transcatheter arterial chemoembolization (TACE) combined with traditional Chinese medicine treating metaphase-advanced hepatocellular carcinoma. Mod Diagn Treat 2002;13:1-3
- Zheng WD, Zheng DH, Zheng WH. Clinical summarization of “Cidan Capsule” in treating 325 primary liver cancer. Shanghai J Tradit Chin Med 2002;12:7-8
- Zhou XY, Wu X, Zuo X, et al. Clinical study of TACE combined with Chinese medicine treating 118 cases of middle-advanced liver cancer. Jiangsu J Tradit Chin Med 2002;23:15-17
- Li CQ, Xu ZS. Research of immunologic therapy or Chinese medicinal-herbs on 108 cases of hepatic cancer after hepatic arterial chemoembolization. China J Cancer Prev Treat 2003;10:1209-10
- Meng ZQ, Xu YY, Liu LM, et al. Clinical evaluation of integration of transcatheter arterial chemoembolization and traditional Chinese medicine in treating metastatic liver cancer. J Chin Integr Med 2003;1:187-8
- Ren HP, Cheng L. Clinical observation on transcatheter arterial chemoembolization combined with Chinese medicine in the treatment of middle-advanced liver cancer. Chin J Integr Tradit West Med 2004;24:838-40
- Wang T. J Observation on the efficacy of Chinese medicine Aidi injection combined with transcatheter arterial chemoembolization treating liver cancer in the elderly patients. J Gansu Coll Tradit Chin Med 2004;21:19-20
- Liu JL, Wang XH, Guo XG, et al. Chemotherapy combined with Chinese herbal recipe treating 33 cases of middle-advanced liver cancer. Tradit Chin Med Res 2005;18:34-6
- Xu ZG, Liu JS, Zhang LG, et al. Transcatheter arterial chemoembolization combined with Chinese medicine treating primary liver cancer. Chin J Surg Integr Tradit West Med 2005;11:480-1
- Zhang YM, Peng DX, Guan HZ. Observation on Shanxian granule combined with intervention therapy treating liver cancer. J Shaanxi Coll Tradit Chin Med 2005;28:31-2
- Zhao ZH, Li H, Li CY, et al. Study on the application of Complex Sophorae injection in the intervention therapy of hepatocellular carcinoma. J Emerg Tradit Chin Med 2005;14:1053-4
- Zhou JF, Xu LQ. Compound Glycyrrhizin tablet combined with transcatheter arterial chemoembolization treating 30 cases of liver cancer. Her Med 2005;24:135-6
- Liang QL, Chen XD, Li XY, et al. Evaluate the clinical effect of composite salviae dripping pill combined with chemotherapy in patients with hepatocellular carcinoma. Chin Arch Tradit Chin Med 2006;24:186-8
- Lin J. Western medicine and Chinese traditional medicine treat the clinic observation of the cancer of the liver hepatic artery emblism chemotherapy period. Chin J Pract Chin Mod Med 2006;19:692-3
- Ou YY, Yu QH, Li GC, et al. Clinical observe report of transcatheter arterial chemoembolization and integrated Chinese and western medicine treating primary liver cancer. Guangzhou Med J 2006;37:69-70
- Wen HY, Peng DX. Integrated Chinese and western medicine treating 32 cases of middle-advanced liver cancer. Shaanxi J Tradit Chin Med 2006;27:26-8
- Feng ZQ, Wu LC, Shen MH, et al. Clinical observe report of Babao pellet compounded of TACE treating the heat toxic and blood stagnation type patients with primary hepatocellular carcinoma. Chin Arch Tradit Chin Med 2007;25:2404-7
- Sun XP, Zhang GY, Xu HM, et al. The clinical study of interventional therapy combining with Jianpi Shugan decoction for treatment of primary hepatic carcinoma with spleen hyperfunction. Chin Imaging J Integr Tradit West Med 2007;5:84-6
- Wang LJ, Li XD, Ma M, et al. Efficacy of Banmao complex injection in chemotherapy of primary hepatic carcinoma. Mod Oncol 2007;15:1812-13
- Xu YQ, Xu JW, Ding R. Treatment of primary liver cancer by TCM formula for Jianpi Huashi Huoxue Jiedu associated with interventional therapy: a clinical observation of 40 cases. J New Chin Med 2007;39:86-7
- Zhang H, Liu XF, Zhao ZH, et al. Effect of Shuganjianpi therapy on immunologic function after transcatheter arterial chemoembolization in liver cancer patients. Clin J Med Offic 2007;35:857-9
- Zhang YH, Zhao CX, Zhou HM, et al. Hepatoprotective effect of Compound Glycyrrhizin on patients undergoing transcatheter hepatic arterial chemoembolization. China Pharm 2007;18:611-12
- Zhong R, Su CZ, Yuan QP. Strengthening qi and activating blood circulation decoction combined with intervention therapy treating 26 cases of primary hepatocellular carcinoma. Shaanxi J Tradit Chin Med 2007;28:1117-18
- McCulloch M, See C, Shu XJ, et al. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. J Clin Oncol 2006;24:419-30
- Cho WC, Chen HY. Clinical efficacy of traditional Chinese medicine as a concomitant therapy for nasopharyngeal carcinoma: a systematic review and meta-analysis. Cancer Invest 2009;27:334-44
- Shen H, Agarwal D, Qi R, et al. Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization. Aliment Pharmacol Ther 2007;26:393-400
- Lu W, Li YH, Yu ZJ, et al. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma. Hepatogastroenterology 2007;54:1499-502